|
Volumn 93, Issue 7-8, 2002, Pages 416-420
|
A chimeric anti-tumor necrosis factor-alfa monoclonal antibody (infliximab) combined with methotrexate in the treatment of active rheumatoid arthritis;Infliximab in associazione con methotrexate nel trattamento dell'artrite reumatoide
|
Author keywords
Anti TNF ; Infliximab; Rheumatoid arthritis
|
Indexed keywords
INFLIXIMAB;
METHOTREXATE;
MONOCLONAL ANTIBODY;
TUMOR NECROSIS FACTOR ANTIBODY;
ADULT;
AGED;
ARTHRITIS;
ARTICLE;
CLINICAL TRIAL;
DISEASE ACTIVITY;
DRUG EFFICACY;
DRUG INDUCED DISEASE;
FEMALE;
HUMAN;
IMMUNOTHERAPY;
MAJOR CLINICAL STUDY;
MALE;
QUALITY OF LIFE;
RHEUMATOID ARTHRITIS;
TREATMENT OUTCOME;
URTICARIA;
ADULT;
ANTIBODIES, MONOCLONAL;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
DRUG EVALUATION;
DRUG THERAPY, COMBINATION;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
MALE;
METHOTREXATE;
MIDDLE AGED;
TIME FACTORS;
|
EID: 0036089149
PISSN: 00341193
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (21)
|